Українська Русский English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)
DOI: https://doi.org/10.15407/fz

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2009; 55(3): 133-140


Peculiaritiesof uric acid balance disorders in patients with type 2 diabetes and metabolic syndrome

V.V. Korpachev, N.M. Gurina, T.I. Korpacheva, A.A. Shuprovich, I.A. Mosendz

    V.P. Komissarenko Institute of Endocrinology andMetabolism of AMS, Kyiv


Abstract

Hyperuricemia (HU) is considered to be a sign of metabolic syndrome as a consequence of purine metabolism disorder. To investigate alterations in uric acid (UA) methabolism, 90 sub­jects (M/F 53/37, aged 58±4 yr) with type 2 diabetes mellitus (DM2) were divided into 5 groups depending on the amount of excreted UA and its content in blood plasma. HU was found in 29% of patients, while hyperpoduction of UA was characteristic in 87% patients. Normo- or hypouricemia in majority of patients were mostly connected to kidney hyperfiltration and “compensatory” hyperuricosuria. HU with decreased UA ex­cretion (“kidney” HU) was characteristic of severe DM2 with reduced kidney filtration rate. “Metabolic” HU with increased formation and excretion rated of UA was observed only in obese men.. Increased insulinemia levels and insulin resistance index (IR) were found in obese patients in comparison with subjects with normal weight, independently of the type of UA excretion disorder. IR strongly correlated with serum UA levels in all groups of patients. The results suggest the significance of insulin resistance and abdominal obesity in UA metabolism in DM2.

References

  1. Балкаров И.М. Подагрическая (уратная) почка. -В кн.: Диагностика и терапия в клинике внутренних болезней. -М. : Здоровье человека, 2004. -С. 219-233.
  2. Барскова В.Г., Насонова В.А., Якунина И.А. и др. О тяжести течения женской подагры // Терапевт. архив. - 2005. - 77, №5. - С. 58-62.
  3. Гуріна Н.М., Корпачев В.В., Шупрович А.А. Порушення обміну сечової кислоти у залежності від ступеня інсулінорезистентності та ожиріння у хворих на цукровий діабет типу 2 : Матеріали з’їзду ендокринологів України, 2007 // Ендокринологія. -2007. - 12,дод. -С.61.
  4. Мадянов И.В., Балаболкин М.И., Григорьев А.А. и др. Гиперурикемия как составляющая часть метаболического синдрома // Пробл. эндокрино­логии. - 1997. - 43, №6. - С.30-33.
  5. Мадянов И.В., Балаболкин М.И., Марков Д.С., Маркова Т.Н.. Основные причины гиперурикемии при сахарном диабете // Терапевт. архив. - 2000. - №2. -С.58-60.
  6. Мухин Н.А., Балкаров П.М., Бритов А.Н. и др. Тубулоинтерстициальный нефрит и артериальная гипертония - клиническое и популяционное значение //Там же. - 1997. - 69, №7. -С.5–10.
  7. Мухин Н.А., Балкаров И.М., Моисеев СВ. и др. Хронические прогрессирующие нефропатии и образ жизни современного человека // Там же. - 2004. -76, №9. -С. 5–10.
  8. Тронько М.Д, Корпачева-Зінич О.В. Тендерні та статеві особливості цукрового діабету - К.: Книга плюс, 2008. - 208 с.
  9. 9. Berne C., Jensevic K., Berglund L. et al. The meta­bolic syndrome as predictor of coronary heart disease, all-cause mortality and insulin resistance - the influence of choice of criteria // Diabetologia. - 2006. - 49, S. 1. - P.230.
  10. 10. Bonora E., Bonadonna R. Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in nondiabetic subjects // Ibid. - 2002. - 45, S.l. N1 (38th EASD Congr.). - P.A184.
  11. Haffner S.M. Sex hormones, obesity, fat distribution, type 2 diabetes and insulin resistance: epidemiological and clinical correlation // Int. J. Obes. Relat. Metab. Disord. - 2000. - 24, №2. - P. 56-58.
  12. Reaven G. The kidney: An anwilling accomplice in syn­drome X // Amer. J. Kidney Dis.- 1997. - 30, №6. -P. 928-931.
  13. Sallstorm J., Carlsson P., Fredholm B. Dibetes-induced hyperfiltration in adenosine A1-receptor deficient mice lacking the tubulo-glomerular feedback mechanism // Diabetologia. - 2006. - 49, S1. - P.652.
  14. Shichiri M., Iwamoto H., Marumo F. Diabetic hypouri-cemia as an indicator of clinical nephropathy // Amer. J. Nephrol. - 1990. - 10, №2. - P.115-122.
  15. Sinagra D., Green D., Scarpitta A.M., Bonaventura V. Serum uric acid, insulin secretion and resistance in nonhyperuricemic and hyperuricemic obese female sub­jects // Int. J.Obes. -1996. - 20, №11. - P.1041-1043.
  16. Taniguchi Y., Hayashi T., Tsumura K. et al. Serum uric acid and risk for hypertension and type 2 diabetes in Japanese men: The Osaca Helth Survey // J. Hypertens. -2001. - 9,№7. - P.1209-1215.

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2019.